Colorectal carcinoma cells (Caco-2) secrete stroma-inducing growth factors in a stroma-oriented direction

Anticancer Research

Volumn 23, Issue 1 A, 2003, Pages 137-141

  Wardelmann, Eva ^a   Kiriakidis, Serafim ^b   Dreschers, Stephan ^a   Behrens, Peter ^a   Heim, Inge ^a   Krischler, Jutta ^a   Pfeifer, Ulrich ^a   Wernert, Nicolas ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Dept of Physiological Chemistry ^*  (Germany)

Author keywords

Caco 2; Colorectal carcinoma cells; Tumor stroma induction; VEGF

Indexed keywords

CYTOKINE; FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL POLARITY; CELL STRAIN CACO 2; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; STROMA;

CACO-2 CELLS; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GROWTH SUBSTANCES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKINS; LYMPHOKINES; PLATELET-DERIVED GROWTH FACTOR; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0344837365     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wernert N: The multiple roles of tumour stroma. Virch Arch 430: 433-43, 1997.
2. Park CC, Bissell MJ and Barcellos-Hoff MH: The influence of the microenvironment on the malignant phenotype. Mol Med Today 6: 324-9, 2000.
3. Wong YC and Wang YZ: Growth factors and epithelial-stromal interactions in prostate cancer development. Int Rev Cytol 199: 65-116, 2000.
4. Liotta LA and Kohn EC: The microenvironment of the tumour-host interface. Nature 411: 375-9, 2001.
5. McCawley LJ and Matrisian LM: Tumor progression: defining the soil round the tumor seed. Curr Biol 11: R25-7, 2001.
6. Chrenek MA, Wong P and Weaver VM: Tumour-stromal interactions. Integrins and cell adhesions as modulators of mammary cell survival and transformation. Breast Cancer Res 3: 224-9, 2001.
7. Wernert N, Löcherbach C, Behrens P, Wellmann A and Hügel A: Presence of genetic alterations in microdissected stroma of human colon and breast cancers. Anticancer Res 21: 2259-64, 2001.
8. Folkman J: The role of angiogenesis in tumor growth. Seminar Cancer Biol 3: 65-71, 1992.
9. Folkman J: Angiogenesis in cancer, vascular, rheumatoid, and other diseases. Nature Medicine 1: 27-31, 1995.
10. Carmeliet P and Jain RK: Angiogenesis in cancer and other diseases. Nature 407: 249-57, 2000.
11. Kraemer M, Tournaire R, Dejong V, Montreau N, Briane D, Derbin C and Binetruy B: Rat embryo fibroblasts transformed by c-jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors. Cell Growth Differ 10: 193-200, 1999.
12. Yancopoulus GD, Davies S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 2427, 2000.
13. Scheele GA, Fukuoka S and Freedman SD: Role of the GP2/THP family Of GPI-anchored proteins in membrane trafficking during regulated exocrine secretion. Pancreas 9: 139-49, 1994.
14. Fais S, Luciani F, Logozzi M, Parlato S and Lozupone F: Linkage between cell membrane proteins and actin-based cytoskeleton: the cytoskeletal-driven cellular functions. Histol Histopathol 15: 539-49, 2000.
15. 1 cells. Am J Nephrol 20: 74-81, 2000.
16. Bergmeyer HU: Standardization of enzyme essays. Clin Chem 18: 1972.
17. Richardson KC, Jareft L and Finke EH: Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol 35: 313-25, 1960.
18. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nature Medicine 1: 27-31, 2000.
19. Dvorak HF, Brown LF, Detmar M and Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-39, 1995.
20. Vandenbunder B, Fafeur V, Wernert N and Stéhelin D: Analyse moléculaire de l'angiogenèse tumorale. Médicine/Sciences 10: 516-27, 1994.
21. Pepper MS: Angiogénèse et morphogenése de l'arbre vasculaire: de la biologie cellulaire à la clinique. Médicine/Science 16: 1378-86, 2000.
22. Yancopoulos GD, Davies S, Gale NW, Rudge JS, Wiegand SJ and Holash J: Vascular-specific growth factors and blood vessel formation. Nature 407: 242-7, 2000.
23. Senger DR, Perruzzi CA, Feder J and Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46: 5629-32, 1986.
24. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR and Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-35, 1993.
25. Gutman A and Wasylyk B: The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. Embo J 9: 2241-6, 1990.
26. Nerlov C, Rorth P, Blasi F and Johnsen M: Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6: 1583-92, 1991.
27. Rorth P, Nerlov C, Blasi F and Johnsen M: Transcription factor PEA3 participates in the induction of urokinase plasminogen activator transcription in murine keratinocytes stimulated with epidermal growth factor or phorbol-ester. Nucleic Acids Res 18: 5009-17, 1990.
28. Liotta LA and Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1: 99-106, 1990.
29. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C and Brambilla E: Expression of c-ets 1, collagenase 1 and urokinase-type plasminogen activator genes in lung carcinomas. Am J Path 147: 1298-310, 1995.
30. Pyke C, Kristensen P, Ralfkiaer E, Grondahl-Hansen J, Eriksen J, Blasi F and Dano K: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138: 1059-67, 1991.
31. Burgoyne RD and Duncan JS: Secretion of milk proteins. J Mammary Gland Biol Neoplasia 3: 275-86, 1998.
32. Shennan DB: Mammary gland membrane transport systems. J Mammary Gland Biol Neoplasia 3: 247-58, 1998,
33. Boyer JL: Bile duct epithelium: frontiers in transport physiology. Am J Physiol 270: G1-5, 1996.
34. Zegers MMP and Hoekstra D: Mechanisms and functional features of polarized membrane traffic in epithelial and hepatic cells. Biochem J 336: 257-69, 1998.
35. Schultheiss G and Diener M: K+ und Cl-conductances in the distal colon of the rat. Gen Pharmacol 31: 337-42, 1998.
36. Wilson PD: Epithelial cell polarity and disease. Am J Physiol 272: F434-42, 1997.
37. Vogel LK and Larsen JE: Apical and non-polarized secretion of serpins from MDCK cells. FEBS Lett 473: 297-302, 2000.
38. Rodriguez-Boulan E and Zurzolo C: Polarity signals in epithelial cells. J Cell Sci Suppl 17: 9-12, 1993.
39. Traub LM and Kornfeld S: The trans-Golgi network: a late secretory sorting station. Curr Biol 9: 527-33, 1997.